ESC Premium Access

Prognostic staging system correctly identifies high risk groups in cardiac transthyretin amyloidosis treated with tafamidis

Topic: Infiltrative Myocardial Disease

Congress Presentation

About the speaker

Mr Maximilian Mueller

Berlin (Germany)
0 follower

7 more presentations in this session

Validation of two simple scores to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction

Speaker: Doctor M. Llevadot Sesmilo (Badalona, ES)

Thumbnail

DPD quantification correlates with ECV and disease severity in patients with ATTR-CM

Speaker: Doctor R. Rettl (Vienna, AT)

Thumbnail

Prognostic significance of right ventricular dysfunction in patients with TTR amyloidosis

Speaker: Doctor S. Istratoaie (Cluj Napoca, RO) Professor E. Donal (Rennes, FR)

Thumbnail

Characterizing the progression of subclinical cardiac amyloidosis through artificial intelligence applied to electrocardiographic images and echocardiograms

Speaker: Doctor E. Oikonomou (New Haven, US)

Thumbnail

Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging

Speaker: Doctor J. Li (Beijing, CN)

Thumbnail

Access the full session

Cardiac amyloidosis: how to stage and score

Speakers: Mr M. Mueller, Doctor M. Llevadot Sesmilo, Doctor R. Rettl, Doctor S. Istratoaie, Professor E. Donal...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations